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Airway clearanceAbstract Introduction: Bronchiectasis is a chronic debilitating condition with abnormal perma-
nent dilatation of the airways causing impaired mucus clearance, despite regular chest physiother-
apy being mainstay of management for bronchiectasis, there is little evidence supporting regular
chest physiotherapy in bronchiectasis which aims to mobilize secretions and facilitate effective
expectoration, providing control of cough and improving airway clearance. The objective of this
study was to compare between the efficacy of 2 techniques of chest physiotherapy ACBT with pos-
tural drainage and conventional chest physical therapy as a method of airway clearance in adults
with productive bronchiectasis.
Methods: The study included 30 subjects, 20 males and 10 females; all having bronchiectasis, the
study was carried out on October 6 at the University Hospital. The participating subjects underwent
conventional chest physical therapy or ACBT following postural drainage as the airway clearance
technique in random order on 14 successive days with twice daily frequency.
Results: There was a significant difference regarding mMRC before and after both ACBT and
conventional physiotherapy, there was a significant improvement regarding FVC and MMEF after
ACBT while there was a significant improvement of FEV1 and MMEF after conventional physio-
therapy. As regards arterial blood gas data comparison, there were significant improvements
regarding PaCO2, PaO2 and PAO2 while there was no significant difference as regards P (A-a)
O2 after both types of physiotherapy techniques. Comparison between the 2 groups regarding
mMRC dyspnea score, spirometry, arterial blood gas data, Leicester cough questionnaire (LCQ)
and sputum wet volume before starting physiotherapy shows no significant difference while there
were significant differences in advance to post ACBT physiotherapy sessions as regards PaO2, P
(A-a) O2 gradient, LCQ (physical domain score and total score) and sputum wet volume.rculosis.
158 H.A. AbdelHalim et al.Conclusion: ACBT with postural drainage is found to be more effective than conventional chest
physical therapy management of bronchiectasis during infective exacerbation.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Bronchiectasis is a chronic debilitating condition, with
abnormal long-lasting dilatation of the airways causing
compromised mucus clearance, chronic bacterial infection
and persistent bronchial inflammation. Subjects suffer from
daily cough, extra sputum production and frequent exacerba-
tions [1]. They may also report breathlessness, wheeze and
fatigue. Such incapacitating symptoms impact on subjects’
health-related quality of life (HRQoL) [2].
Away from any sensible suspicion, one of the greatest
accomplishments of medicine in the treatment of bronchiecta-
sis is physiotherapy, where it effectively reduces its morbidity
and mortality especially during repeated infective exacerbation
[3]. Physiotherapy aims to loosen secretions and facilitate effi-
cient expectoration, through control of cough and enhancing
airway clearance, Therefore it is broadly advocated as a pillar
of management of bronchiectasis.
Despite little evidence supporting the routine use of regular
chest physiotherapy in bronchiectasis it provided significant
profits compared with no chest physiotherapy [4].
Previous small studies in bronchiectasis have compared var-
ious techniques, some realized small alterations being achieved
by many methods of chest physiotherapy as regards improve-
ment in functional capacity and HRQoL [5,6]. More studies
are needed to explore prospective benefits on other outcome
measures in order to determine a method to be superior; how-
ever, patient preference was subjective besides the related
effects on lung function during the exacerbations [1].
The aim of this study is to compare the efficacy of twice
daily physiotherapy using active cycles of the breathing
method with postural drainage (ACBT-PD) against conven-
tional chest physiotherapy in bronchiectasis subjects not
previously practicing regular chest physiotherapy.
Methods
Subjects
The study was conducted on 30 subjects, recruited from the
inpatient department of October 6 University Hospital, com-
plaining of infective exacerbation of bronchiectasis which
was defined as a clinical deterioration with all of the following:
increasing cough, increasing sputum volume and worsening
sputum purulence [7].
The subjects were randomly assigned to receive either active
cycle breathing technique physiotherapy with postural drainage
or the conventional chest physiotherapy technique and accord-
ingly they were divided into 2 groups; group (1): included 15
subjects who underwent the active cycle breathing physiother-
apy technique with postural drainage; 10 males and 5 females,
their mean age was (53.73 ± 14.78 years); and group (2):
included 15 subjects who underwent the conventional chestphysiotherapy technique; 10 males and 5 females, their mean
age was (49.40 ± 15.43 years). The study was approved by
the review board of pulmonary medicine department of the
Ain Shams University and signed informed consents were
obtained from all subjects. All subjects were subjected to the
following on admission: medical history including a history of
smoking, Leicester Cough Questionnaire (LCQ) and modified
medical research council (mMRC) dyspnea scale (filled by the
attendant physician), clinical examination including anthropo-
metric measurements (weight, height and calculated body mass
index (BMI), sputum collection daily with monitoring of
amount (in mL) and type, sputum examination including
(Gram stain, Zeihl Nelsen stain, culture and sensitivity) high
resolution chest computerized tomography with contrast, elec-
trocardiogram, liver and renal function tests, spirometry, arte-
rial blood gas analysis, calculated PAO2 (using alveolar gas
equation) and P(A-a)O2 gradient.
Exclusion criteria
Participants were excluded if they have:
(1) Smoking history or physician diagnosis of COPD [8].
(2) A clinical diagnosis of asthma [9].
(3) Interstitial lung disease (clinical/radiological diagnosis);
pneumonia (clinical/radiological diagnosis); acute or
chronic other comorbid disease (clinical/laboratory
diagnosis).
(4) Respiratory failure.
(5) Hemoptysis.
(6) Inability to perform the physiotherapy techniques.
(7) Corticosteroid intake during the previous 4 weeks.
All subjects received standard medical treatment in the
form of: empirical antibiotics, inhaled bronchodilator
(b2-agonist and/or anticholinergic), mucolytic. The antibiotic
regimen was modified later on (if needed) according to the
results of the sputum culture and sensitivity.
Cough specific health-related quality of life (HRQoL)
HRQoL was measured using the Leicester Cough
Questionnaire (LCQ) which measures the physical, psycholog-
ical and social impact of chronic cough [10]. It consists of 19
items with responses based on a 7-point scale and has been
validated in subjects with bronchiectasis. A higher score indi-
cates less impact on HRQoL [11].
mMRC dyspnea scale
A scoring method was used which uses a simple grading system
to assess a patient’s level of dyspnea. It is composed of 5 grades
(0–4) with higher scores indicating more dyspnea severity [12].
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A helical CT scanner (Hi Speed Advantage; GE Medical
Systems, DX/i) was used for conventional contiguous scanning
with a slice thickness of 10 mm to screen for chest abnormali-
ties, followed by HRCT scanning at full inspiration (at total
lung capacity (TLC) level) with 1-mm collimation of
120 kVp, 200 mA, pitch 1.0.
Spirometry
Spirometry was done using Spirometrics, ENC Flowmate
according to the American Thoracic Society/European
Respiratory Society standards in all subjects [13].
Arterial blood gas analysis
Arterial blood sample withdrawn from the radial artery
using a 23 gauge heparinized syringe was sent to the laboratory
for analysis using BAYER RAPIDLAB 248 blood gas
analyzer.
Alveolar gas equation
PAO2 ¼ ðFiO2  ðPatmos PH2OÞÞ  ðPaCO2=RQÞ:
The FiO2 is the fraction of inspired oxygen (expressed as a
decimal).
 Patmos is the ambient atmospheric pressure, which is
760 mmHg at sea level.
 PH2O is vapor pressure of water at 37 C and is equal to
47 mmHg (760–47 mmHg).
 RQ is the respiratory quotient or respiratory coefficient (the
ratio of CO2 eliminated divided by the O2 consumed), and
its value is typically 0.8.
The alveolar gas equation is most commonly used in the
calculation of the Alveolar – arterial oxygen gradient: A-a
gradient = PAO2  PaO2 [14].
Sputum collection
Any sputum produced during and following either treatment
was collected into the same plastic beaker (labeled mL scale)
and the volume was measured.
Intervention
Group (1)
Active cycle breathing chest physiotherapy technique with
postural drainage. It consists of 3 steps: subjects were sitting
comfortably in a standard chair.
1. Breathing control: subject breathes at a normal rate and
depth using the lower chest.
2. By resting one hand on the epigastrium allowing the subject
to breath in slowly and deeply using the lower chest (Pause)
then breathe out fully but not forcefully. Repeated 2 to 3
times. Return to breathing control.3. Sputum removal: subject takes a slightly bigger than nor-
mal breath in, making the subject to open the mouth and
keep it O shaped. Breathing out more forcefully by con-
tracting the abdominal muscles while keeping the mouth
and throat open. It should sound like a forced sigh as
HUFFING.
Return to breathing control till the patient is ready to begin
another cycle. The patient is advised to start coughing any spu-
tum if necessary [15,16].
Each standardized ACBT cycle lasted around 2 min and
was repeated for 15–20 min with postural drainage/gravity
assisted drainage i.e. the use of specific positioning in which
gravity enhances mucus transport from distal bronchi.
Repeated twice daily with a minimum 6 h duration [17].
Group (2)
Conventional chest physiotherapy technique. The use of gravity
assisted position combined with diaphragmatic breathing exer-
cises with percussion. This technique is done for 15–20 min
twice daily [18].
Antibiotic therapy
All subjects completed 14 days of antibiotic therapy and doses
used were as recommended for bronchiectasis/cystic fibrosis in
the British National Formula [19].
Side-effects
No adverse side-effects were reported and no changes to treat-
ment regimens occurred. All subjects successfully completed
14 days of treatment.
Data analysis
Data variables of the 2 groups were compared by independent
sample T-test. Comparison within a group before and after the
intervention was done using the paired t-test. Analysis was per-
formed using statistical software (SPSS version 17; SPSS, Inc.,
Chicago, IL). Data are presented as mean ± SD, p< 0.05 was
considered significant.
Results
The study included 30 subjects, 20 males (66.7%) and 10
females (33.3%); all having bronchiectasis diagnosed clinically
and radiologically. Their mean age was 51.56 ± 15 years. The
participating subjects were randomly assigned to chest physio-
therapy either ACBT-PD (included 15 subjects) or conven-
tional physiotherapy (included 15 subjects). The
characteristic data of both groups are presented in Table 1.
Comparison between both groups regarding age and
anthropometric data measures using independent sample stu-
dent t-test. There were no significant difference, the results
are shown in Fig. 1.
Comparison as regards mMRC dyspnea score before and
after ACBT-PD using the paired t-test. There was a significant
difference (t= 6.325, p= 0.000). These results are shown in
Fig. 2. Comparison as regards mMRC dyspnea score before
Table 1 Characteristics of all patients.
Total Group 1 Group 2
Min Max Mean SD Min Max Mean SD Min Max Mean SD
Age (yrs) 24 78 51.57 15.01 25 78 53.73 14.78 24 73 49.40 15.43
Weight (kg) 51 155 77.17 0.48 51 155 78.27 32.79 57 120 76.07 17.79
Height (cm) 150 180 167.88 25.94 157 180 166.93 6.89 150 178 168.83 6.88
BMI (kg/cm2) 17.65 55.46 27.39 6.84 17.65 55.46 28.08 11.39 20.62 41.04 26.7 6.11
Descriptive data of participating patients, data are presented as minimum, maximum values; mean ± SD.
Figure 1 Comparison between the 2 groups regarding anthropometric data using independent sample t-test. There were no significant
differences between the 2 groups regarding all anthropometric data.
Figure 2 Comparison as regards MMRC dyspnea score before
and after ACBT using the paired t-test. There was significant
difference regarding MMRC (t= 6.325, p= 0.000).
Figure 3 Comparison as regards MMRC dyspnea score before
and after conventional physiotherapy using the paired t-test.
There was significant difference regarding MMRC (t= 5.245,
p= 0.000).
160 H.A. AbdelHalim et al.and after conventional physiotherapy using the paired t-test.
There was a significant difference (t= 5.245, p= 0.000).
These results are shown in Fig. 3.
Spirometry data were compared within group (1) before
and after ACBT-PD using paired t-test showed that there were
significant differences regarding FVC (t= 4.812, p= 0.000)
and MMEF (t= 2.229, p= 0.043); there were no significant
differences as regards FEV1 (t= 0.907, p= 0.380) and
FEV1/ FVC ratio (t= 1.613, p= 0.129). These results are
shown in Fig. 4. Also spirometry data were compared beforeand after conventional physiotherapy within group (2) using
the paired t-test; there were significant differences regarding
FEV1 (t= 2.219, p= 0.044) and MMEF (t= 4.532,
p= 0. 000); there were no significant differences as regards
FVC (t= 0.386, p= 0.705) and FEV1/FVC ratio (t= 
1.758, p= 0.101). The results are shown in Fig. 5.
As regards arterial blood gas data comparison before and
after ACBT-PD using paired t-test. There were significant
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Figure 4 Comparison as regards spirometry data before and after ACBT using the paired t-test. There was significant difference
regarding FVC (t= 4.812, p= 0.000) and MMEF (t= 2.229, p= 0.043); there was no significant difference as regards FEV1
(t= 0.907, p= 0.380) and FEV1/FVC ratio (t= 1.613, p= 0.129).
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Figure 5 Comparison as regards spirometry data before and after conventional physiotherapy using the paired t-test. There were
significant differences regarding FEV1 (t= 2.219, p= 0.044) and MMEF (t= 4.532, p= 0.000); there was no significant difference
as regards FVC (t= 0.386, p= 0.705) and FEV1/FVC ratio (t= 1.758, p= 0.101).
Methods of airway clearance in adults with bronchiectasis 161differences regarding PaCO2 (t= 6.775, p= 0.000), PaO2
(t= 12.548, p= 0.000) and PAO2 (t= 6.775,
p= 0.000); there was no significant difference as regards P
(A-a) O2 (t= 1.104, p= 0.288). These results are shown in
Fig. 6. Comparison as regards arterial blood gas data before
and after conventional physiotherapy using paired t-test.
There were significant differences regarding PaCO2
(t= 3.696, p= 0.002), PaO2 (t= 10.490, p= 0. 000) and
PAO2 (t= 3.696, p= 0.002); there was no significant differ-
ence as regards P (A-a) O2 (t= 0.332, p= 0.745) as shown in
Fig. 7. Comparison between the 2 groups regarding mMRC
dyspnea score, spirometry, arterial blood gas data, Leicester
cough questionnaire (LCQ) and sputum wet volume before
starting physiotherapy using student t-test was done; there
were no significant differences between both groups as illus-
trated in Table 2. Comparison between the 2 groups regarding
mMRC dyspnea score, spirometry, arterial blood gas data,
LCQ and sputum wet volume after the physiotherapy session
end using student t-test; there were no significant differences
between both groups except for PaO2 (t= 2.119, p= 0.043),P (A-a) O2 gradient (t= 2.632, p= 0.014), Leicester cough
questionnaire (LCQ) (physical domain score (t= 0.118,
p= 0.023) and total score (t= 0.642, p= 0.019)) and sputum
wet volume (t= 2.402, p= 0.023) as presented in Table 3
(see Fig. 8).
Discussion
Although bronchiectasis doesn’t have actual prevalence in
many countries, it remains a cause of excessive morbidity
[20]. In the current situation of limited health resources of
the developing countries, it is important to provide interven-
tions which not only contribute to improved HRQoL, but pos-
itively influence on disease progression and prognosis
especially during the exacerbations which worsen lung func-
tions on the reasoning of the copious secretions and the low
cough flow during sickness.
This study assisted in the choice of technique of physiother-
apy for the treatment of subjects with bronchiectasis in clinical
practice.
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Figure 6 Comparison as regards arterial blood gas data before and after ACBT using the paired t-test. There was significant difference
regarding PaCO2 (t= 6.775, p= 0.000), PaO2 (t= 12.548, p= 0.000) and PAO2 (t= 6.775, p= 0.000); there was no significant
difference as regards P (A-a) O2 (t= 1.104, p= 0.288).
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having bronchiectasis with a heterogeneous clinical profile,
secondary to the multiple etiologies from which it may
originate, diagnosed clinically and radiologically, they were
all in acute infective exacerbation. Subjects that were admitted
to the inpatient department received their optimum medical
treatment and were randomly assigned to chest physiotherapy
set as 15–20 min twice daily ACBT-PD (included 15 subjects)
or conventional physiotherapy (included 15 subjects). This
study selected a twice daily physiotherapy regimen following
previous studies assessing different physiotherapy techniques
for bronchiectasis have achieved compliance with this fre-
quency [6,21].
The results of this study revealed no significant differences
between the 2 groups regarding all anthropometric data, There
were also no significant differences between the 2 groups
before physiotherapy regarding clinical (modified MRC dysp-
nea score), spirometry, arterial blood gas data, Leisester cough
questionnaire (including its 3 domains and the total score) and
sputum wet volume.0 
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significant difference regarding PaCO2 (t= 3.696, p= 0.002), PaO2 (t
was no significant difference as regards P (A-a) O2 (t= 0.332, p= 0.As regards the statistical analysis of the data after
ACBT-PD and conventional physiotherapy there was a signif-
icant improvement in MMRC dyspnea score in both groups
without significant difference between them.
Regarding spirometry data of the subjects included in this
study there was a significant improvement in some spirometry
data in both groups, including a significant improvement of
airway obstruction and small airway affection, which had been
achieved due to the 14 day duration of regular treatment. This
was in contrary to other studies with a more brief treatment
duration where there was no significant improvement in any
of spirometry data [22].
This study demonstrated statistical differences regarding
FVC and MMEF (percentage predicted) of the subject group
(1) who had undergone ACBT-PD where this technique clears
and mobilizes excess pulmonary secretions from the small air-
ways at the periphery thus an alternation of thoracic expansion
with controlling breathing followed by the forced expiratory
technique i.e. forced expiration with an opened glottis associ-
ated with gravity assisted postural drainage gave a superiorityPAO2 P(A-a)O2
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fter conventional physiotherapy using the paired t-test. There was
= 10.490, p= 0. 000) and PAO2 (t= 3.696, p= 0.002); there
745).
Table 2 Comparison between both groups before physiotherapy.
ACBT Conventional t p
mMRC 2.93 ± 0.96 2.87 ± 1.73 0.131 0.897
FVC 70.69 ± 22.52 70.85 ± 30.26 0.017 0.986
FEV1 57.19 ± 13.81 54.09 ± 20.46 0.486 0.630
FEV1/FVC ratio 84.25 ± 17.23 74.29 ± 18.66 1.520 0.140
MMEF 31.64 ± 14.11 32.26 ± 17.93 0.105 0.917
PC02 52.56 ± 6.25 55.91 ± 8.21 1.258 0.219
PaO2 73.0 ± 13.22 60.67 ± 16.71 2.242 0.330
PAO2 84.03 ± 7.81 79.82 ± 10.27 1.258 0.219
P(A-a)O2 gradient 11.02 ± 7.91 19.17 ± 9.11 2.614 0.140
LCQ Physical 4 ± 2 3.7 ± 1.9 0.435 0.122
Psychological 3 ± 1.3 3 ± 1.4 0.337 0.216
Social 3 ± 1.2 3 ± 1 0.326 0.084
Total 10 ± 1.4 9 ± 1.7 0.514 0.115
Sputum wet volume (ml) 43 ± 9.02 43.67 ± 9.16 0.201 0.842
There were no significant differences between the 2 groups before physiotherapy regarding clinical (modified MMRC dyspnea score),
spirometry, arterial blood gas data, Leicester cough questionnaire (LCQ) (including its 3 domains and the total score) and sputum wet volume.
Table 3 Comparison between both groups after physiotherapy.
ACBT Conventional t p
mMRC 1.60 ± 0.91 2.00 ± 1.46 0.899 0.376
FVC 73.97 ± 23.46 71.93 ± 31.66 0.200 0.843
FEV1 57.68 ± 13.97 56.71 ± 20.69 0.150 0.882
FEV1/FVC ratio 81.70 ± 15.6 77.82 ± 18.08 0.630 0.534
MMEF 36.67 ± 12.83 38.92 ± 18.52 0.387 0.701
PC02 47.02 ± 6.71 49.66 ± 9.37 0.887 0.382
PaO2 80.86 ± 13.02 69.13 ± 17.02 2.119 0.043
*
PAO2 90.96 ± 8.39 87.66 ± 11.71 0.887 0.382
P(A-a)O2 gradient 10.1 ± 7.33 18.52 ± 10.00 2.632 0.014*
LCQ Physical 6 ± 3.2 4 ± 2.9 0.118 0.023*
Psychological 5 ± 2 5 ± 2.2 0.232 0.121
Social 3 ± 2.9 3 ± 1.8 0.341 0.316
Total 14 ± 3 12 ± 4.2 0.642 0.019*
Sputum wet volume (ml) 14.67 ± 3.99 19 ± 5.73 2.402 0.023*
There were no significant differences between the 2 groups after physiotherapy regarding clinical (modified MMRC dyspnea score), spirometry
and arterial blood gas data except for PaO2, P (A-a) O2 gradient, Leicester cough questionnaire (LCQ) (physical domain score and total score)
and sputum wet volume.
* Significant.
Figure 8 Comparison regarding sputum wet volume before and after each type of physiotherapy (i.e. ACBT and conventional) using the
paired t-test. There was significant improvement in sputum wet volume after both types of physiotherapy (t= 19.75, p= 0.000) and
(t= 13.22, p= 0.000) respectively.
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per day with respect to the amount of sputum in group (2)
leading to improvement of alveolar ventilation and optimizing
ventilation perfusion matching, which increase alveolar oxygen
tension and finally improves tissue oxygenation. These results
reason the significant difference regarding PaO2 and P (A-a)
O2 gradient in advance to the subjects of the group that had
undergone ACBT-PD, while insignificant improvement of
FEV1would have been noted as a result of middle and large
airway obstruction due to the forced expiratory maneuver in
ACBT.
Regarding group (2) subjects who underwent conventional
physiotherapy their spirometry data developed significant dif-
ferences in FEV1 and MMEF (percentage predicted) where the
manual percussion of the chest wall with the strategic position-
ing of the subjects for mucus drainage was associated with
diaphragmatic breathing and coughing thus giving priority to
improvement of airway obstruction from the mucus plug and
significant improvement of the amount of sputum of the sub-
jects, but with less respiratory muscle training.
Previous studies nullified statistical improvement in spirom-
etry data to both techniques and this could be due to the dif-
ference in the study designs and methodologies [22].
In this study sputum volume is measured by a simple non-
invasive method to measure the effectiveness of airway clear-
ance, subjects were accustomed to expectorate sputum and
discouraged from swallowing it. The results of this study
demonstrated a significant difference of the amount of sputum
per day only after both techniques of ACBT-PD and conven-
tional physiotherapy.
As regards comparison of arterial blood gas data after both
ACBT-PD and conventional physiotherapy, there were signif-
icant differences regarding PaO2, and P (A-a) O2 gradient.
Despite this study investigating the difference in the efficacy
of both types of regular chest physiotherapy techniques in aid-
ing airway clearance and improvement in spirometry data, it
also reflected one of the major goals of the management of
bronchiectasis: an improvement in HRQoL. Specifically, it
assessed the impact of the predominant symptom of bronchiec-
tasis, cough severity by the Leicester cough questionnaire
which was developed and validated to determine the impact
of cough severity on quality of life [11]. It proved a statistical
significant difference as regards the physical domain score and
the total score giving advance to the ACBT-PD.
In conclusion, this study found that regular chest physio-
therapy in bronchiectasis has significant benefits in both the
compared chest physiotherapy techniques. ACBT-PD
achieved a superior improvement in airway clearance reflected
by the amount of sputum per day, better arterial blood oxy-
genation due to increased PaO2, and minimization of P (A-a)
O2 gradient and improved the impact of cough severity on
quality of life signaled by the significant progression of the
physical domain score and the total score of the Leicester
cough questionnaire, which determines one of the major goals
in the management of bronchiectasis.
Further studies are needed to specifically address different
comparisons between various chest physiotherapy techniques
with optimal frequency and duration and above all the tailored
technique for each patient with bronchiectasis to explore
potential benefits on other outcome measures.Conflict of interest
There is no conflict of interest.
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